This is a metaanalysis of all available studies as of December 1990 that have evaluated the
effect of antihypertensive pharmacologic therapy on left ventricular structure examined by …

Objective.—To determine the ability of various antihypertensive agents to reduce left
ventricular hypertrophy, a strong, blood pressure—independent cardiovascular risk factor, in …

OBJECTIVE: To provide an update on the ability of different antihypertensive drugs to
reduce left ventricular hypertrophy in essential hypertension. DATA SOURCES: Relevant …

In numerous studies, left ventricular hypertrophy (LVH) has been clearly established to be a
strong blood pressure (BP) independent risk factor for cardiovascular morbidity and …

Left ventricular hypertrophy (LVH), as assessed by ECG or echocardiography, is a powerful
independent coronary risk factor. The present overview of 104 studies sets out to compare …

The availability of echocardiography has allowed direct determinations of left ventricular wall
thickness and calculation of left ventricular mass. As a result, the past decade has witnessed …

It has been clearly demonstrated that left ventricular (LV) hypertrophy is a strong blood
pressure independent risk factor for cardiovascular morbidity and mortality in the general …

PURPOSE: Antihypertensive medications have different effects on left ventricular mass. We
conducted a meta-analysis of double-blind trials that measured the effects of …

Reversal of left ventricular (LV) hypertrophy with medical therapy has been studied
increasingly in patients with systemic hypertension. However, serial changes of LV function …

Blood pressure–lowering therapy reduces left ventricular mass, but the question of whether
differences exist among drug classes has not been fully resolved. Our aim was to compare …